The partnership also allows Sanofi to use the company's adjuvant, Matrix-M ... One-trick pony? The Novavax logo displayed on ...

Novavax's stock was trading down more than 6% Tuesday afternoon after the company lowered its guidance for sales for the year ...

For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day and thank you for standing by. Welcome to the IAS Q3 ...

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License ...

Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare ...

From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...

A treatment of acute myeloid leukemia being developed by Sanofi (SNY) US Services was granted FDA orphan designation, according to a post to the agency’s website. Published first on TheFly ...

“The development of Muse, a result of our ongoing collaboration with OpenAI and Formation Bio, represents another proof point ...

The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...

The company is banking on revenue from its Sanofi deal and vaccines in development, including an experimental COVID-flu ...